Document:

<PAGE>

                                                                    EXHIBIT 10.1

                         CONSENT OF INDEPENDENT AUDITOR

The audits referred to in our report dated 4 September 2002 includes the related
financial statement schedule as of 30 June 2002, 30 June 2001 and 30 June 2000,
and for the years ended 30 June 2002, 30 June 2001 and 30 June 2000 incorporated
by reference in the registration statements on Form S-8 and Form F-3. This
financial statement schedule is the responsibility of the group's management.
Our responsibility is to express an opinion on this financial statement schedule
based on our audit. In our opinion, such financial statement schedule, when
considered in relation to the consolidated financial statements taken as a
whole, presents fairly in all material respects the information set forth
therein.

We consent to the incorporation by reference of our report dated 4 September
2002 with respect to the consolidated balance sheet of Diageo plc and
subsidiaries as at 30 June 2002 and 30 June 2001, and the related consolidated
profit and loss accounts, consolidated statement of total recognised gains and
losses and consolidated cash flows for each of the years in the three year
period ended 30 June 2002, which report appears in the Annual Report (Form 20-F)
for the year ended 30 June 2002 in the following Registration Statements:

         Registration Statement on Form F-3 (File No. 333-10410); and
         Registration Statement on Form S-8 (File No. 333-11460); and
         Registration Statement on Form S-8 (File No. 333-11462); and
         Registration Statement on Form S-8 (File No. 333-9770); and
         Registration Statement on Form S-8 (File No. 333-8092); and
         Registration Statement on Form S-8 (File No. 333-8094); and
         Registration Statement on Form S-8 (File No. 333-8096); and
         Registration Statement on Form S-8 (File No. 333-8098); and
         Registration Statement on Form S-8 (File No. 333-8090); and
         Registration Statement on Form S-8 (File No. 333-8100); and
         Registration Statement on Form S-8 (File No. 333-8106); and
         Registration Statement on Form S-8 (File No. 333-8102); and
         Registration Statement on Form S-8 (File No. 333-8104)

KPMG Audit Plc
Chartered Accountants
Registered Auditor

London, England
  November 2002

                                      E-1Exhibit 10.1

                          AMENDED EMPLOYMENT AGREEMENT

This employment agreement (the "Agreement") is effective as of October 15, 2002
(the "Effective Date"), by and between Keryx Biomedical Technologies Ltd., an
Israeli company with it principal place of business at Hartom 7, Jerusalem (the
"Company") and Rony Seger, I.D. No. ____________, of __________________________
(the "Employee").

Whereas the Employee has been employed by the Company as its Chief Scientific
Officer;

Whereas the Employee is returning to his position at the Weizmann Institute of
Science as of the date of this Agreement;

Whereas the Company desires to continue to employ the Employee on a part-time
basis, in the position of Senior Scientific Advisor (the "Position");

Whereas the Employee desires to continue his employment by the Company and to
fulfill the responsibilities of the Position on a part-time basis; and

Whereas the parties desire to set forth the new conditions of employment
pursuant to which the Company will employ the Employee;

It is hereby agreed by and between the parties as follows:

1.    Preamble

The preamble to this Agreement and any attachments thereto are an integral part
of this Agreement.

2.    Job Description

The Employee shall be responsible for rendering such advice and services to the
Company as may be reasonably required by the Company including, without
limitation, advising the Company with respect to the direction of the Company's
research and product development and business development activities. He shall
report directly to the Chief Executive Officer. The description of
responsibilities set forth herein shall serve as a general statement of the
duties, responsibilities and authority of the Employee.

3.    Working Hours

The Employee shall be employed by the Company on a part-time basis, namely for
not more than one (1) day per week (inclusive of mealtime). The Employee agrees
that his position is considered to be a management position as defined in the
Hours of Work and Rest Law - 1951, which requires a special measure of personal
trust. Accordingly, the provisions of the Hours of Work and Rest Law - 1951
shall not

                                      - 1 -

<PAGE>

apply and the Employee shall not be entitled to receive any additional payment
for his work other than those that are set forth in this Agreement.

4.    Term of Agreement

This Agreement shall take effect from the Effective Date and shall remain in
effect unless it is earlier terminated as hereinafter provided.

5.    Annual Salary

      5.1. The Employee's annual salary shall be as follows:

            5.1.1. The Employee shall receive an annual gross salary of fifty
                  seven thousand six hundred dollars ($57,600), payable in New
                  Israeli Shekels according the representative rate of exchange
                  in effect each month at the time Company salaries are
                  calculated. The Employee's salary shall be paid in twelve
                  equal installments, monthly in arrears.

            5.1.2. The salary set forth in paragraph 5.1.1, above, shall be
                  referred to as the "Global Salary". The linkage of the Global
                  Salary to the United States dollar is in lieu of any
                  generally-applicable increases, whether the statutory cost of
                  living increase ("Tosefet Yoker") or any other industry-wide
                  increase applicable as the result of collective bargaining
                  agreements or other order of the Ministry of Labor and Welfare
                  (such as Tzavei Harhava). By signing this Agreement and
                  accepting employment pursuant to its terms, the Employee
                  represents that s/he will not claim any such increase.

            5.1.3. The Employee shall not be entitled to receive from the
                  Company any salary or payment of any kind other than the
                  Global Salary and other payments specifically set forth in
                  this Agreement or properly authorized by the Board of
                  Directors and, should the Employee be a director of the
                  Company at the time such other payments not specifically
                  included in this Agreement are made, by the shareholders of
                  the Company.

      5.2.  Other Terms of Employment

            5.2.1. Bonuses: The Employee shall be eligible to receive one or
                  more bonuses during any calendar year in the discretion of the
                  Chief Executive Officer, acting in consultation with the Board
                  of Directors.

            5.2.2. Expenses: The Employee shall be entitled, in accordance with
                  the Company's standard policy in effect from time to time, to
                  be reimbursed for expenses incurred in Israel and abroad in
                  connection with Company business against receipt by the
                  Company of appropriate vouchers, receipts or other proof of
                  the Employee's expenditures.

            5.2.3. Car Allowance: The Employee shall be entitled to receive a
                  monthly amount of two hundred and eighteen dollars ($218),
                  payable in New

                                      -2-
<PAGE>

                  Israeli Shekels, to reimburse him for the upkeep and
                  maintenance entailed in the use of his personal automobile for
                  business purposes.

            5.2.3. Reserve Duty: The Employee shall be entitled to receive his
                  full Global Salary and other payments while performing reserve
                  duty, provided that any amount received by the Employee from
                  the I.D.F. or any other source (excluding Damei Calcala) is
                  transferred to the Company or, in the alternative, an amount
                  equal to that received from the I.D.F. or any other source is
                  deducted from the Global Salary payable to the Employee.

            5.2.4. Annual Leave and Recreation Pay (Damei Havra'a): The Employee
                  shall be entitled to four (4) working days of paid annual
                  leave each year. The Employee shall not be allowed to accrue
                  more than ten (10) working days of annual leave except in
                  unusual circumstances and with the permission of the Company.
                  Should the Employee's annual leave balance exceed ten (10)
                  days at the end of any calendar year, the excess number of
                  days shall be paid out in accordance with the provisions of
                  the Annual Leave Law - 1951. Notwithstanding the foregoing,
                  any unused annual leave accrued by the Employee prior to the
                  Effective Date shall be paid out as part of the first payment
                  of his Global Salary following the Effective Date. The Company
                  shall also pay the Employee for one (1) day of recreation
                  (damei havra'a) each year in accordance with the law and the
                  normal practice of the Company in effect from time to time.

            5.2.5. Sickness: The Employee shall be entitled to the number of
                  days for sick leave permitted by law. Compensation for sick
                  days utilized shall be paid according to his Global Salary
                  only upon the presentation of medical documentation as
                  required by the Company. It is understood and agreed that
                  unused sick leave cannot be redeemed by the Employee. For the
                  avoidance of doubt, it is understood and agreed that the
                  payments made by the Company in consideration of sick leave
                  covers all obligations of the Company pursuant to the Sick
                  Leave Law - 1976.

            5.2.6. Discontinuation of the Employee's Participation in Other
                  Benefit Programs: The Employee acknowledges and agrees that as
                  of the Effective Date, his participation in the Company's
                  Continuing Education Fund (Keren Hishtalmut) and Manager's
                  Insurance Program (Bituach Minhalim) shall cease and that the
                  Company shall have no further obligations to contribute its
                  portion or to deduct the Employee's contribution to those
                  programs.

6.    Termination of Employment

      6.1.  Either party may terminate the Employee's employment with the
            Company without cause at any time upon three (3) month's notice. The
            Company shall have the right, in its sole discretion, to require the
            Employee to continue working for the Company during the notice
            period.

                                      -3-
<PAGE>

      6.2.  The Employee's employment shall be terminated by his death or
            disability. (For purposes of this section, "disability" shall be
            deemed to have occurred if the Employee is unable, due to any
            physical or mental disease or condition, to perform his normal
            duties of employment for 90 consecutive days or 120 days in any
            twelve-month period.) In such an event, he shall be entitled to
            continue to receive his annual salary for three (3) months following
            his last day of actual employment by the Company. Such amount shall
            be in addition to any severance payment he is entitled to receive
            according the provisions of the Severance Compensation Law - 1963.
            In addition, the Board of Directors shall take the necessary steps
            so that (a) any outstanding, but unvested, options granted to the
            Employee shall vest upon the effective date of his termination; and
            (b) the period during which the Employee shall be permitted to
            exercise such options shall be extended to two (2) years from the
            effective date of his termination as defined in the Share Option
            Plan governing the options in question. Should the Employee's
            employment be terminated as a result of his death, the benefits
            granted herein, shall be granted instead to his lawful heir or
            heirs.

      6.3.  Notwithstanding the foregoing, the Company may terminate the
            Employee immediately and without prior notice in the following
            circumstances: (a) a material breach of the Employee's obligations
            pursuant to paragraphs 8.7, 8.8 and 8.11 (confidentiality and
            non-competition); (b) a material breach by the Employee of any other
            provision of this Agreement, which is not cured by the Employee
            within fifteen (15) days after receiving notice thereof from the
            Company containing a description of the breach or breaches alleged
            to have occurred; (c) the habitual neglect or gross failure by the
            Employee to adequately perform the duties of his position; (d) any
            act of moral turpitude or criminal action connected to his
            employment with the Company or his place of employment; or (e) the
            Employee's refusal to comply with or his violation of lawful
            instructions of the Chief Executive Officer or the Board of
            Directors.

      6.4.  In the event that Employee's employment has been terminated in
            accordance with paragraph 6.3, above, the Employee shall not be
            entitled to receive any of the severance payments set forth in
            paragraph 6.2, above.

7.    Taxes and Other Payments

      7.1.  Unless otherwise specifically provided for in this Agreement, the
            Company shall not be liable for the payment of taxes or other
            payments for which the Employee is responsible as result of this
            Agreement or any other legal provision, and the Employee shall be
            personally liable for such taxes and other payments.

      7.2.  The Employee hereby agrees that the Company shall deduct from his
            Global Salary the Employee's national insurance fees, income tax and
            other amounts required by law or the terms of this Agreement. The
            Company shall provide the Employee with documentation of such
            deductions.

                                      -4-
<PAGE>

      7.3   The Employee hereby agrees that his employment by the Company
            pursuant to this Agreement shall be considered for tax and national
            insurance purposes as secondary to his employment by the Weizmann
            Institute of Science.

8.    The Obligations of the Employee

      8.1.  The Employee agrees to devote his time, energy, abilities and
            experience to the performance of his duties, effectively and in good
            faith.

      8.2.  Keryx shall not require the Employee to act on its behalf in any
            manner that would represent a conflict between the interests of
            Keryx, on one hand, and the Weizmann Institute, on the other hand.
            Such acts shall include, but not be limited to, the carrying out of
            research for Keryx that overlaps or continues research he has
            carried out at the Weizmann Institute as of the date of this
            Agreement; the evaluation of technology belonging to the Weizmann
            Institute that Keryx is interested in licensing; and conducting
            negotiations on Keryx's behalf with the Weizmann Institute in
            connection with technology belonging to the Weizmann Institute that
            Keryx is interested in licensing.

      8.3   During the period of his employment, the Employee must notify the
            Company immediately should he accept employment, whether or not
            during regular business hours, for pay or without pay by any other
            party other than the Company or the Weizmann Institute. Such
            notification shall be accompanied by a certification by the Employee
            that such employment will not conflict with or prevent him from
            fulfilling his obligations to the Company.

      8.4.  The Employee agrees to immediately inform the Company of any Company
            issue or transaction in which the Employee has a direct or indirect
            personal interest and/or where such issue or transaction could cause
            a conflict of interest for the Employee in the fulfillment of his
            responsibilities as an employee of the Company.

      8.5.  The Employee hereby gives irrevocable instructions and permission to
            the Company to deduct from any amounts owed to the Employee by the
            Company, including amounts payable as severance compensation, (a)
            any debt he has or will have to the Company; and/or (b) any amount
            that was wrongfully or mistakenly paid to him by the Company. Any
            such amounts to be deducted shall be calculated in real terms as of
            the date of the deduction, including linkage to cost of living
            index.

      8.6.  The Employee declares that the terms and conditions of his
            employment are personal and confidential and will not be disclosed
            by him.

      8.7.  The Employee declares that he is free to enter into this Agreement
            and that he has no obligations of any kind to any third party that
            would impair this Agreement, either as an employee or an independent
            contractor. The Employee further declares that as long as he remains
            an employee of the Company, he will not incur any such obligations.

                                      -5-
<PAGE>

      8.8.  The Employee agrees to keep confidential (a) all professional,
            scientific, commercial, and business information; and (b) any other
            information or document that comes to the Employee's knowledge in
            connection with the affairs of the Company (collectively, the
            "Confidential Information"), and agrees not to use or exploit the
            Confidential Information or to disclose it to any third party where
            such use, exploitation or disclosure in not directly related to the
            affairs of the Company, unless the Company gives prior written
            authorization of such disclosure. Nothing in the foregoing shall be
            construed to prevent the Employee from disclosing or using any
            information which the Employee can show by written documentation was
            in the public domain or enters into the public domain through no
            improper act on the Employee's part or on the part of any of the
            Company's employees or was in his possession prior to his joining
            the Company or disclosed to the Employee after he has left the
            Company on a non-confidential basis by a person authorized to do so.
            The Employee agrees immediately to return all such material and
            reproductions in his possession to the Company upon request and in
            any event upon termination of employment.

      8.9.  The Employee agrees that during his employment by the Company and
            thereafter he (a) will not disseminate or otherwise make use of the
            Confidential Information or of other non-public information of which
            he learned while working for the Company, except where such
            dissemination or use is directly related to the affairs of the
            Company; (b) will maintain the confidentiality of the Confidential
            Information; and (c) will not in any way act to injure the
            reputation of the Company or any of its affiliated companies.

      8.10. The Employee understands and recognizes that his services to the
            Company are special and unique and agrees that, during the term of
            this Agreement, and for a period of 12 months from the date of
            termination of his employment hereunder, he shall not in any manner,
            directly or indirectly, on behalf of himself or any person, firm,
            partnership, joint venture, corporation or other business entity
            ("Person"), enter into or engage in any business directly
            competitive with the Company's business, either as an individual for
            his own account, or as a partner, joint venturer, employee, agent,
            consultant, salesperson, officer, director or shareholder of a
            Person operating or intending to operate within the area that the
            Company is, at the date of termination, conducting its business (the
            "Restricted Businesses"); provided, however, that nothing herein
            will preclude the Employee from holding one percent (1%) or less of
            the stock of any publicly traded company or from holding a position
            with a Person who does not engage in a business directly competitive
            with the Restrictive Businesses so long as the Employee works in a
            division of such Person which carries on a bona fide business which
            is not directly competitive with the Restricted Businesses.

      8.11. For a period of 12 months after the termination of this Agreement,
            the Employee shall not interfere with or disrupt or attempt to
            disrupt the Company's business relationship with any of its
            partners, customers or suppliers.

                                      -6-
<PAGE>

      8.12. During the term of this Agreement, and for 12 months thereafter, the
            Employee shall not, directly or indirectly, without the prior
            written consent of the Company:

            (a)   solicit or induce any employee of the Company or any
                  affiliated company to leave the employ of the Company or any
                  affiliated company or hire for any purpose any employee of the
                  Company or any affiliated company or any employee who has left
                  the employment of the Company or any affiliated company within
                  six months of the termination of said employee's employment
                  with the Company or any affiliated company; or

            (b)   solicit or accept employment or be retained by any party who,
                  at any time during the term of this Agreement, was a customer
                  or supplier of the Company or any affiliated company where his
                  position will be related to the business of the Company or any
                  affiliated company; or

            (c)   solicit or accept the business of any customer or supplier of
                  Keryx or any Affiliate with respect to products similar to
                  those supplied by Keryx.

      8.13  In the event that the Employee breaches any provisions of paragraphs
            8.10, 8.11 and/or 8.12, or there is a threatened breach, then, in
            addition to any other rights which the Company may have, the Company
            shall be entitled, without the posting of a bond or other security,
            to injunctive relief to enforce the restrictions contained herein.
            In the event that an actual proceeding is brought in equity to
            enforce these provisions, the Employee shall not argue as a defense
            that there is an adequate remedy at law nor shall the Company be
            prevented from seeking any other remedies that may be available.

      8.14. Upon termination of his employment, the Employee agrees to assist
            the Company with an orderly transition of his responsibilities and
            to return to the Company any documents, information and/or materials
            that were given to him or which were created by him in connection
            with his employment.

9.    Intellectual Property Rights

The provisions of Section 7 of the agreement executed on August 30, 2001,
between the Employee and Keryx Biopharmaceuticals, Inc. are hereby incorporated
by reference and shall govern the intellectual property rights and obligations
the Employee and the Company.

10.   Indemnification

The agreement executed between the Company's parent company and the Employee
that provides for the indemnification of the Company's officers and directors
shall remain in full force and effect. In addition, the Company, or its parent
company, shall maintain an appropriate level of Directors and Officers Liability
coverage, which coverage shall include the Employee.

                                      -7-
<PAGE>

11.   General

      11.1. It is agreed that the provisions of this Agreement represent the
            full scope of the agreement between the parties and that neither
            side shall be bound by any promises, declarations, exhibits,
            agreements or obligations, oral or written, that are not included in
            this Agreement prior to its execution. Any changes or amendments to
            this Agreement must be in writing and signed by both parties.

      11.2. This Agreement shall be governed by, and construed and interpreted
            under, the laws of the State of Israel. The parties agree that any
            legal claim lodged by one party against the other arising from the
            terms of this Agreement shall be adjudicated only by the appropriate
            court in Jerusalem, Israel.

      11.3. If any provision of this Agreement shall be declared by a court of
            competent jurisdiction to be invalid, illegal or incapable of being
            enforced in whole or in part, the remaining conditions and
            provisions or portions thereof shall nevertheless remain in full
            force and effect and enforceable, and no provision shall be deemed
            dependent upon any other covenant or provision unless so expressed
            herein.

      11.4. The rights, benefits, duties and obligations under this Agreement
            shall inure to, and be binding upon, the Company, its successors and
            assigns, and upon the Employee and his legal representatives. This
            Agreement constitutes a personal service agreement, and the
            performance of the Employee's obligations hereunder may not be
            transferred or assigned by the Employee.

      11.5  The failure of either party to insist upon the strict performance of
            any of the terms, conditions and provisions of this Agreement shall
            not be construed as a waiver or relinquishment of future compliance
            therewith or with any other term, condition or provision hereof, and
            said terms, conditions and provisions shall remain in full force and
            effect. No waiver of any term or condition of this Agreement on the
            part of either party shall be effective or any purpose whatsoever
            unless such waiver is in writing and signed by such party.

      11.6  The headings of Sections are inserted for convenience and shall not
            affect any interpretation of this Agreement.

12.   Notices

      12.1. A notice that is sent by registered mail to a party at its address
            as set forth in paragraph 12.2, below, shall be deemed received
            three (3) days after its posting, and the receipt stamped by the
            post office shall represent definitive evidence of the date of
            mailing.

                                      -8-
<PAGE>

      12.2. The addresses of the parties for the purposes of this Agreement are:

            Keryx Biomedical Technologies Ltd.:

            Hartom 7
            POB 23706
            Jerusalem 91236

            Employee:

IN WITNESS WHEREOF the parties have hereunto set their hands at the place and on
the date first above written.

Keryx Biomedical Technologies Ltd.
By

/s/ Benjamin Corn                          /s/ Rony Seger
--------------------------------           --------------------------------
                                           Employee

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}]]